Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis
Public ClinicalTrials.gov record NCT03073200. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and efficacy of ixekizumab in pediatric participants with moderate-to-severe plaque psoriasis.
Study identification
- NCT ID
- NCT03073200
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 201 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 28, 2017 (Actual)
- Primary completion
- Feb 7, 2019 (Actual)
- Completion
- Mar 23, 2021 (Actual)
- Last update posted
- Sep 27, 2021
2017 – 2021
United States locations
- U.S. sites
- 25
- U.S. states
- 16
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | — |
| Tien Q. Nguyen, MD inc. DBA First OC Dermatology | Fountain Valley | California | 92708 | — |
| Children's National Medical Center | Washington D.C. | District of Columbia | 20010 | — |
| Olympian Clinical Research | Clearwater | Florida | 33756 | — |
| Solutions Through Advanced Research, Inc. | Jacksonville | Florida | 32256 | — |
| University of South Florida | Tampa | Florida | 33612 | — |
| Forward Clinical Trials, Inc | Tampa | Florida | 33624 | — |
| Advanced Medical Research | Sandy Springs | Georgia | 30328 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| Arlington Dermatology | Rolling Meadows | Illinois | 60008 | — |
| The South Bend Clinic | South Bend | Indiana | 46617 | — |
| University of Missouri | Columbia | Missouri | 65212 | — |
| SSM Health Cardinal Glennon Children's Hospital | St Louis | Missouri | 63104 | — |
| Psoriasis Treatment Center of Central New Jersey | East Windsor | New Jersey | 08520 | — |
| University of North Carolina Dermatology and skin Cancer Cen | Chapel Hill | North Carolina | 27516 | — |
| Wright State Physicians Dermatology | Fairborn | Ohio | 45324 | — |
| Ohio State Univ College Of Medicine | Gahanna | Ohio | 43230 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Dermatology and Skin Surgery Center | Exton | Pennsylvania | 19341 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Modern Research Associates PLLC | Dallas | Texas | 75231 | — |
| Texas Dermatology and Laser Specialists | San Antonio | Texas | 78218 | — |
| Virginia Clinical Research | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03073200, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 27, 2021 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03073200 live on ClinicalTrials.gov.